Skip to main content
. 2009 Aug 19;20(3):539–550. doi: 10.1111/j.1750-3639.2009.00328.x

Figure 3.

Figure 3

Proteome changes in T98G glioma cells following miR‐184 overexpression (A) or miR‐17 inhibition (B). (A) Expression of nucleophosmin 1 (Npm1) was found to be significantly (P < 0.05) down‐regulated in T98G cells transfected with miR‐184 precursors (Pre‐184) as compared to control‐transfected cells (Pre‐NC). (B) Protein expression of Pold2 was significantly (P < 0.05) up‐regulated in T98G cells transfected with miR‐17 inhibitors (Anti‐17) as compared to control‐transfected cells (Anti‐NC). Npm1 is a predicted target of miR‐184, while Pold2 is a predicted target of miR‐17 according to the Sanger Institute mirBase target database (http://microrna.sanger.ac.uk/index.shtml).